ECM
ExodusPoint Capital Management Portfolio holdings
AUM
$8.21B
1-Year Return
14.38%
This Quarter Return
+1.95%
1 Year Return
+14.38%
3 Year Return
+47.96%
5 Year Return
+100.26%
10 Year Return
–
AUM
$9.63B
AUM Growth
-$72.9M
(-0.75%)
Cap. Flow
-$20.3M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
16.95%
Holding
2,067
New
586
Increased
380
Reduced
342
Closed
717
Top Buys
| 1 |
Duke Energy
DUK
|
+$164M |
| 2 |
Broadcom
AVGO
|
+$99.6M |
| 3 |
Apple
AAPL
|
+$97.4M |
| 4 |
Chevron
CVX
|
+$94M |
| 5 |
Citigroup
C
|
+$89.8M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$407M |
| 2 |
Mondelez International
MDLZ
|
+$131M |
| 3 |
Johnson & Johnson
JNJ
|
+$107M |
| 4 |
NiSource
NI
|
+$90.6M |
| 5 |
PPL Corp
PPL
|
+$85.2M |
Sector Composition
| 1 | Technology | 14.93% |
| 2 | Financials | 14.7% |
| 3 | Healthcare | 12.06% |
| 4 | Utilities | 11.17% |
| 5 | Real Estate | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Amylyx Pharmaceuticals
AMLX
$1.04B
| $402K | ﹤0.01% |
+106,237
| New | +$402K |
|
1102
Northeast Bank
NBN
$941M
| $398K | ﹤0.01% |
+4,341
| New | +$398K |
|
1103
Standard Motor Products
SMP
$889M
| $397K | ﹤0.01% |
+12,820
| New | +$397K |
|
1104
Polaris
PII
$3.22B
| $395K | ﹤0.01% |
+6,848
| New | +$395K |
|
1105
Cass Information Systems
CASS
$565M
| $394K | ﹤0.01% |
9,632
+4,484
| +87% | +$183K |
|
1106
Franklin Covey
FC
$240M
| $393K | ﹤0.01% |
+10,460
| New | +$393K |
|
|
ADAM
1107
Adamas Trust, Inc. Common Stock
ADAM
$644M
| $390K | ﹤0.01% |
64,305
-64,946
| -50% | -$394K |
|
1108
Preferred Bank
PFBC
$1.16B
| $389K | ﹤0.01% |
+4,500
| New | +$389K |
|
1109
Spyre Therapeutics
SYRE
$945M
| $389K | ﹤0.01% |
16,691
+6,958
| +71% | +$162K |
|
1110
Lands' End
LE
$475M
| $385K | ﹤0.01% |
+29,336
| New | +$385K |
|
1111
Prime Medicine
PRME
$726M
| $385K | ﹤0.01% |
+131,732
| New | +$385K |
|
1112
Credit Acceptance
CACC
$5.33B
| $379K | ﹤0.01% |
807
-5,240
| -87% | -$2.46M |
|
1113
Definitive Healthcare
DH
$432M
| $378K | ﹤0.01% |
+92,076
| New | +$378K |
|
1114
Geron
GERN
$810M
| $377K | ﹤0.01% |
+106,441
| New | +$377K |
|
1115
Tango Therapeutics
TNGX
$727M
| $377K | ﹤0.01% |
+121,993
| New | +$377K |
|
1116
Utz Brands
UTZ
$1.12B
| $377K | ﹤0.01% |
24,055
+13,019
| +118% | +$204K |
|
1117
Titan Machinery
TITN
$451M
| $374K | ﹤0.01% |
+26,466
| New | +$374K |
|
1118
Voyager Therapeutics
VYGR
$232M
| $373K | ﹤0.01% |
65,830
+32,834
| +100% | +$186K |
|
1119
SmartFinancial
SMBK
$627M
| $372K | ﹤0.01% |
+12,000
| New | +$372K |
|
1120
National Research Corp
NRC
$369M
| $371K | ﹤0.01% |
21,035
+694
| +3% | +$12.2K |
|
1121
CION Investment
CION
$517M
| $370K | ﹤0.01% |
32,459
-21,652
| -40% | -$247K |
|
1122
Victory Capital Holdings
VCTR
$4.58B
| $369K | ﹤0.01% |
+5,636
| New | +$369K |
|
1123
Lightwave Logic
LWLG
$417M
| $365K | ﹤0.01% |
173,842
+162,737
| +1,465% | +$342K |
|
1124
Boston Omaha
BOC
$425M
| $362K | ﹤0.01% |
25,550
+13,417
| +111% | +$190K |
|
1125
UroGen Pharma
URGN
$869M
| $358K | ﹤0.01% |
+33,598
| New | +$358K |
|